The global market for 3D medical and surgical imaging platforms should increase from $4.5 billion in 2018 to nearly $10.4 billion in 2023 at a compound annual growth rate (CAGR) of 18.1% for 2018-2023.
Report Scope:
The scope of this report is broad. It covers components, applications, end users and modes of deployment in 3D medical and surgical platforms. The market has been segmented by components into hardware, software and services. Revenue forecasts for 2018–2023 are given for each segment and regional market with estimated value derived from the revenue of manufacturers’ total revenues. The main geographic markets—North America, Europe, Asia Pacific and Rest of World (ROW) are included.
The report also includes a discussion of the major players across each region in the 3D medical and surgical imaging platforms market. Further, it explains the major drivers and regional dynamics of the global 3D medical and surgical imaging platforms market and current trends within the industry.
Key industry acquisitions and strategic alliances are given for the three-year period 2015–2018 (June).
This report also examines the main patent trends within the industry and profiles 25 market players that deal in 3D medical and surgical imaging platforms.
The report concludes with a special focus on the vendor landscape and includes detailed profiles of the main vendors in the global 3D medical and surgical imaging platforms market.
Report Includes:
- 151 data tables and 66 additional tables
- An overview of the global 3D medical and surgical imaging platform market
- Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Characterization and quantification of the market potential for 3D medical and surgical imaging platform by geographical regions, components, applications, end users and mode of deployment
- Discussion of major drivers, technological advancements and regional dynamics of the global 3D medical and surgical imaging platform market, and current trends within the industry
- Assessment of the vendor landscape and detailed profiles of the major vendors in the global 3D medical and surgical imaging platform market
- Company profiles of major players in the market, including Ambra Health, Esaote Spa, GE Healthcare, Koninklijke Philips NV, Medtronic Inc., Siemens Healthcare, Stryker Corp. and Whiteclouds
Summary
3D medical and surgical imaging platforms refer to the incorporation of various components including hardware, software and services in imaging modalities. These pieces come together in order to improve patient outcomes by offering premium optics with uncompromised platform integration, cross specialty functionality, advanced imaging capabilities, etc. Medical and surgical imaging platforms are an important part of the healthcare industry, widely used for clinical purposes. 3D medical and surgical platforms enable imaging techniques used to create 3D images of the body or body parts to help doctors diagnose accurately. The advantages proposed by 3D medical and surgical imaging platforms are image pre-processing, virtual cutting, volume rendering, manipulation, surface rendering and virtual endoscopy.
Surging development of modern visualization methods and technology platforms along with rising demand of 3D imaging in diagnosis and monitoring of chronic diseases are contributing to growth in the global 3D medical and surgical imaging platforms market. A shift toward minimally invasive procedures and rising adoption of hybrid operating rooms are also providing traction for the market. Secondary factors such as frequent promotion of innovative solutions from platform providers in the market and investments in healthcare IT are also driving the global 3D medical and surgical imaging platforms market.
Rising demand for 3D imaging in the diagnosis and monitoring of chronic diseases is the main driver for the growth in the global 3D medical and surgical imaging platforms market. Increased demand for 3D medical imaging is noted due to its vast applications in cardiology and oncology. Heart valve replacement is the most common procedure in cardiology. Transcatheter aortic valve replacement is one minimally invasive heart valve replacement procedure. Positioning the new heart valve is a serious concern for surgeons. Due to the importance of positioning, surgeons prefer 3D angiography imaging software to view the anatomy during placement of heart valves. As the number of heart surgeries increases across the globe, use of 3D medical imaging and surgical platforms is expected to increase over the forecast period 2018–2023. Preference for minimally invasive procedures also calls for the adoption of 3D medical and surgical imaging platforms. According to the International Society of Aesthetic Plastic Surgery, non-surgical procedures accounted for a 10% increase from 2015–2016. In 2015, the total number of non-surgical procedures were around 12.0 million, then 13.2 million in 2016.
The global 3D medical and surgical imaging platforms market is projected to rise at a CAGR of REDACTED% during the forecast period of 2018–2023. In 2023, total revenues are expected to reach more than $REDACTED billion (an increase of nearly $REDACTED billion) from $REDACTED billion in 2017.
This report provides an analysis based on each market segment including components, applications, deployment and end users. The components segment is further sub-segmented into hardware, software and services. The software segment of the 3D medical and surgical imaging platforms market held the largest market share (REDACTED% in 2017) in terms of revenue, followed by hardware and services. By 2023, total revenue from software in the 3D medical and surgical imaging platforms market is expected to reach nearly $REDACTED billion. Additionally, the software segment is expected to rise at the highest CAGR (REDACTED%) of all segments, through 2023.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Introduction
Report Scope
Regulations
United States
European Union
Australia
China
Japan
ASEAN
South Africa
Investment Analysis
3D Medical and Surgical Imaging Platforms by Component
Hardware
Software
Services
3D Medical and Surgical Imaging Platforms by Application
Ultrasound
Digital Radiography
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Nuclear Imaging
Mammography
3D Medical and Surgical Imaging Platforms by Deployment
On-premise-based Platform
Cloud-based Platform
Web-based Platform
3D Medical and Surgical Imaging Platform by End User
Hospitals
Ambulatory and Healthcare Settings
Diagnostic Centers
Research Centers
Industry Growth Drivers
Development of Modern Visualization Methods and Technology Platforms
High Adoption of Minimally Invasive Procedures
Adoption of Hybrid Operating Rooms as Part of an Efficient Medical Infrastructure
Increasing Use of Automation Technologies in the Healthcare Sector
Rising Demand for 3D Imaging in Diagnosing and Monitoring of Chronic Diseases
New Innovative Solutions by Platform Providers in the Market
Increasing Aging Population
Increased Prevalence of Chronic Diseases
Rising Healthcare Expenditures
Chapter 4 Market Breakdown by Component
Hardware
Software
Services
Chapter 5 Market Breakdown by Application
Ultrasound
3D Ultrasound Scanning Techniques
Increasing Incidence of Infectious and Chronic Diseases Drives the Ultrasound Market
Research and Development in CVD
Digital Radiography
Advantages of X-Ray Machines
Magnetic Resonance Imaging
Advancements in 3D Imaging
Computed Tomography
3D Surgical and Medical Imaging Platforms for CT Scan
Common Applications of CT Scans
Application of CT in Pediatric Patients
Benefits
Advancements in Imaging Systems
Nuclear Imaging
Market Drivers
Positron Emission Computed Tomography (PET) Imaging
Single Photon Emission Computed Tomography (SPECT) Imaging
Scintigraphy Imaging
Estimation of Disability-Adjusted Life Years (DALYs) for Neurological Diseases
Technological Advancements in Nuclear Imaging:
Mammography
Endoscopy
Advantages of 3D Endoscopy System
Types
Innovation and New Products
Others (Laparoscopy, X-ray, etc.)
Advancements in Laparoscopy
Chapter 6 Market Breakdown by Type of Deployment
On-premise-based Platforms
Cloud-based Platform
Benefits
Drawbacks
Web-based Platform
Benefits
Drawbacks
Chapter 7 Market Breakdown by End User
Hospitals
According to Breast Cancer (Australia)
Cancer Research U.K. Statistics
Increased Number of Hospitals Worldwide
Increasing Prevalence of Cardiovascular Diseases
Hybrid Operating Room
Patient-Centric Trend
Ambulatory and Healthcare Settings
Diagnostic Centers
Technological Advancements in 3D Medical and Surgical Imaging Platforms
Increasing Healthcare Expenditure
Research Centers
Chapter 8 Market Background by Region
North America
United States
Canada
Mexico
Europe
United Kingdom
France
Germany
Spain
Italy
Rest of Europe (ROE)
Asia Pacific
China
India
Japan
Australia
Rest of Asia Pacific
Rest of the World (ROW)
Latin America
Middle East and Africa (MEA)
Chapter 9 Industry Structure
Innovations within the Industry
Supply Chain Analysis
Suppliers
Research and Development (R&D)
Manufacturing
Distribution
End Users
Opportunities in Supply Chain
Artificial Intelligence and Analytics
Block-Chain and Internet of Things (IoT)
Robotics
Chapter 10 Company Profiles
AMBRA HEALTH
ARTERYS
BRAINLAB AG
CANON MEDICAL SYSTEMS LTD. (ACQUIRED TOSHIBA CORP.)
DEPUY SYNTHES
ESAOTE SPA
FOVIA
GE HEALTHCARE
KITWARE INC.
KONINKLIJKE PHILIPS NV
LEXMARK INTERNATIONAL INC.
MACH7 TECHNOLOGIES LTD.
MCKESSON CORP.
MEDTRONIC INC.
NAVEGATIUM
NDS SURGICAL IMAGING LLC
NERVEVISION INC.
OLYMPUS CORP.
PIE MEDICAL IMAGING BV
PLANMECA OY
QUIBIM SL
SIEMENS HEALTHCARE
STRYKER CORP.
SURGICAL THEATER LLC
WHITECLOUDS